QS
QuantumScape CorporationThesis. QuantumScape remains a binary, pre-revenue technology bet: zero sales, a ~$100m/quarter cash burn, and a $904m cash pile that funds roughly two years of runway before dilution. The June Honda R&D agreement re-rated the platform narrative and provides real validation, but with the shares at $6.79 sitting 64% below the 52-week high and analysts skewed hold-to-sell, the risk-reward is balanced rather than compelling. Hold: this is a call option on QSE-5 commercialization, not an investable earnings stream.
Scoreboard
At $6.79 QS carries a $4.18bn market cap and $3.34bn enterprise value against $835m net cash, sitting -64.4% below its $19.07 52-week high and only +15.1% above the $5.90 low — position 0.07 in range, deep in the lower quartile and below both the $7.72 50-day and $9.99 200-day averages. Consensus mean target of $7.16 implies a thin +5.5% upside, but dispersion is extreme: a $2.50 low versus $10.00 high frames the binary nature of the name. We anchor to $7.00, near consensus, reflecting a fairly-valued option pending commercial proof.
QoQ Changes
Q1-2026 revenue was $0.0m — QuantumScape remains entirely pre-revenue — while net loss narrowed to $100.8m (-$0.16 basic EPS) from a $100.1m loss (-$0.17) in Q4-2025 and a $114.7m loss (-$0.20) in Q2-2025. The sequential improvement is cost discipline, not commercialization; the top line stays zero.
With no revenue, gross/operating/EBITDA margins are not meaningful, but the absolute burn is trending favorably: operating loss improved to $109.2m from $123.6m three quarters ago and EBITDA loss narrowed to -$83.0m from -$92.6m. The trajectory shows opex control as the company holds pre-production.
FCF margin is n/a on zero revenue, and FCF yield runs ~-3.6%, reflecting persistent cash outflow to fund R&D and pilot lines. Operating cash burn approximates the ~$83-90m quarterly EBITDA loss, the single most important number for the equity.
Total cash of $904.7m ($1.47/share) against just $69.2m debt leaves $835.5m net cash and a fortress liquidity profile — current ratio 20.9x, quick ratio 20.7x. The optically high 6.24x debt/equity is a book-equity artifact; solvency is not the near-term risk, dilution is.
Traditional multiples are inapplicable: no P/E (forward P/E -10.0x), no P/S, negative EV/EBITDA of -8.4x. The only anchors are 3.76x price-to-book ($1.80 book value) and ~$3.34bn EV for a zero-revenue platform — a valuation that discounts substantial future licensing success.
The defining recent action is the June 18 joint research agreement with Honda R&D, framed as building a battery platform beyond automotive and driving a +12.9% single-day pop. Headcount sits at ~700; no M&A or restructuring in the data, and management continues to guide toward QSE-5 field trials as the commercialization gate.
Ownership & Insider Activity
Finnhub SEC Form 4 data shows net insider selling of ~$3.16m over the window: CTO Timothy Holme sold 150,320 shares at $9.30 (~$1.40m) plus 40,615 at $9.30 (~$0.38m) around June 2, and CFO Kevin Hettrich made an open-market sale of 9,800 shares at $7.94 (~$78k) on June 22 — the balance of June-3 director activity was routine compensation grants (code A) at zero cost, not conviction buying. With 18.7% of float short (94.7m shares, 4.3-day cover) and institutions holding only 41.9%, the tape is thinly conviction-held and vulnerable to squeeze-and-fade dynamics. Insider distribution into strength alongside heavy short interest is a cautionary cross-signal.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-06-22 | HETTRICH KEVIN | Chief Financial Officer | 9,800 | $77.8K |
| 2026-06-03 | RIBAR GEOFFREY GEORGE | Director | 24,183 | $0.00 |
| 2026-06-03 | SEGERS DENNIS LYNN | Director | 24,183 | $0.00 |
| 2026-06-03 | NIEBERGALL ROSS | Director | 24,183 | $0.00 |
| 2026-06-03 | HANLEY JENEANNE MICHELLE | Director | 24,183 | $0.00 |
| 2026-06-03 | LOVETT GENA C. | Director | 24,183 | $0.00 |
Earnings Quality
| Period | Actual EPS | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
| 2026-03-31 Q1 | $-0.16 | $-0.18 | +$0.02 | +12.33% |
| 2025-12-31 Q4 | $-0.17 | $-0.18 | +$0.01 | +4.49% |
| 2025-09-30 Q3 | $-0.18 | $-0.21 | +$0.03 | +12.62% |
| 2025-06-30 Q2 | $-0.20 | $-0.21 | +$0.01 | +2.91% |
QS beat consensus in 4 of the last 4 quarters with an average +8.1% surprise, but these are 'smaller-loss' beats (e.g., -$0.16 vs -$0.18 estimated in Q1-2026), signaling disciplined burn management rather than earnings power.
Surprises are noisy but net favorable (+12.3%, +4.5%, +12.6%, +2.9%), indicating analysts consistently model burn slightly too pessimistically — a modest positive for guidance credibility, though irrelevant until revenue arrives.
Analyst Action
| Month | Distribution | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|
| 2026-07 | 0 | 0 | 9 | 5 | 3 | |
| 2026-06 | 0 | 0 | 9 | 5 | 3 | |
| 2026-05 | 0 | 0 | 9 | 5 | 4 | |
| 2026-04 | 0 | 0 | 9 | 5 | 4 |
Finnhub's recommendation series is static and bearish-tilted: 0 strong buy / 0 buy / 9 hold / 5 sell / 3 strong sell in July 2026, essentially unchanged from April (the strong-sell count actually eased from 4 to 3). No bulls, a heavy hold-to-sell skew.
Momentum is flat-to-mildly-bearish with zero upgrades or downgrades in the trailing 15 days — the Street is in wait-and-see mode pending commercial evidence.
Seven Essential Metrics
Zero revenue, -$100.8m quarterly net loss, ROE -38.0% and ROA -23.0% — no profitability, by design at this stage.
Revenue growth is n/a off a zero base; the only 'growth' is a narrowing loss (EBITDA -$83.0m vs -$92.6m three quarters prior).
FCF yield ~-3.6% with ~$83-90m quarterly cash burn; the balance sheet funds it, but generation is deeply negative.
$835.5m net cash and only $69.2m debt — the 6.24x debt/equity ratio is a book-equity distortion, not real leverage.
Beta 2.62, 18.7% short interest, pre-revenue binary technology risk and dilution overhang despite the cash cushion.
Forward P/E -10.0x, EV/EBITDA -8.4x, 3.76x P/B — a $3.34bn EV on zero revenue prices in commercialization not yet proven.
Implied shares outstanding (615m) exceed basic (578m); equity funding of the burn structurally dilutes holders, no buyback.
No dividend and none expected; all capital is directed to R&D and scale-up.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
SLDP Solid Power, Inc. | negative | n/a (nascent) | negative | Net cash | n/m (loss) |
ENVX Enovix Corporation | negative | ~high (early ramp) | negative | Net cash | n/m (loss) |
AMPX Amprius Technologies | negative | ~100%+ | negative | <1x | n/m (loss) |
MVST Microvast Holdings | ~breakeven | ~20-30% | negative | 2x | n/m |
Against the solid-state/next-gen battery cohort, QS is the best-capitalized ($835m net cash) but among the least commercially advanced — Amprius and Microvast already book revenue, Enovix is ramping shipments, while QS remains pre-revenue. Its premium EV reflects the perceived TAM of an automotive-grade solid-state license (now Honda-validated) rather than any current fundamental. Relative to peers that are converting product to cash, QS trades on optionality alone.
Business & Strategy
There is effectively no revenue mix today — QuantumScape is a pre-commercial R&D platform developing solid-state lithium-metal battery cells (the QSE-5). Future revenue is intended to come from licensing/royalty and cell-manufacturing arrangements (e.g., the Cobra/Raptor separator process and OEM partnerships), a model reinforced by the Honda R&D agreement.
Prospective customers are automotive OEMs and, increasingly, adjacent power applications — Volkswagen/PowerCo historically and now Honda R&D via the June 2026 joint research agreement.
The intended model is capital-light licensing and royalties on QS's separator and cell technology, supplemented by JV manufacturing; none of this is yet generating sales.
R&D headcount (~700 employees), pilot-line and separator (Cobra) equipment scale-up, and materials science iteration dominate the ~$100m quarterly cash burn.
The potential moat is a defensible IP portfolio around a ceramic solid-state separator that claims to solve dendrite formation and enable lithium-metal anodes — a genuinely hard technical problem. That moat is unproven at automotive scale, and OEM validation (Honda, VW) is the only external evidence it is real.
Monetary-Policy Sensitivity
- High-beta (2.62) long-duration profile amplifies rate moves
- Lower discount rate lifts present value of far-off cash flows
- Cheaper capital eases future dilution/financing terms
As a zero-cash-flow, long-duration 'story' equity with a 2.62 beta, QS is acutely sensitive to the discount rate — a dovish pivot disproportionately re-rates it versus profitable peers. Conversely, the June 5 rate-hike scare that plunged the Nasdaq >3% is exactly the regime that punishes this name hardest.
SWOT Analysis
- $835.5m net cash and ~20x current ratio — multi-year runway with negligible debt
- Honda R&D validation (June 2026) reinforces the platform/licensing thesis
- Differentiated, IP-protected solid-state ceramic separator technology
- 100% consensus beat rate on disciplined, narrowing cash burn
- Zero revenue and ~$100m/quarter net loss with no commercial timeline certainty
- Structural dilution — implied shares (615m) already exceed basic (578m)
- Insider net selling ~$3.16m (CTO and CFO) into recent strength
- Deep technical execution risk on scaling QSE-5 to automotive volume
- Additional OEM licensing/JV deals beyond VW and Honda
- Expansion into non-auto applications (grid, consumer, aviation)
- Solid-state as the next leg of the EV/energy-storage transition
- Rate cuts re-rating long-duration growth equities
- Competing solid-state and advanced-cell efforts (Toyota, Samsung SDI, QuantumScape peers)
- 18.7% short interest and 2.62 beta driving violent volatility
- Dilutive capital raises if runway compresses
- Commercialization slippage eroding the platform narrative
Catalysts & Event Risks
- Q3 2026Q2-2026 earnings & QSE-5 update
Next quarterly print will be scrutinized for cash-burn trajectory and any field-trial or sampling milestones.
- Q4 2026Honda R&D program progress
Early deliverables from the joint research agreement would substantively validate the licensing model.
- 2026-H2QSE-5 customer sampling / B-sample milestones
Evidence of automotive-grade cell shipments to OEMs is the key de-risking event.
- Q3 2026Cobra separator scale-up milestones
Progress on high-throughput separator manufacturing underpins any path to commercial volume.
- 2026-H2Fed rate-path pivot
A dovish shift would disproportionately lift this high-beta, long-duration name.
The catalyst calendar is milestone-driven rather than earnings-driven: technology validation (sampling, Honda deliverables) matters far more than the P&L. Absent hard commercialization proof, rallies remain narrative- and macro-driven and prone to fade.
Technical Analysis
QS is in a clear downtrend, -64.4% off its $19.07 high and sitting at just 0.07 in its 52-week range, below both the $7.72 50-day and $9.99 200-day moving averages. The $5.90 52-week low is critical support; a break invites price discovery lower, while reclaiming the 50-day at ~$7.72 is the first resistance bulls must clear. With 18.7% short interest and elevated volume (31.4m vs 24.5m average), the setup is a high-beta range trade — favorable risk-reward only near the $5.90 floor, not at current levels. The technical posture argues for patience over chasing.
Verdict
Macro context. The EV/battery complex remains pressured by demand normalization and rate uncertainty — the June 5 hot-jobs print and rate-hike jitters that sank the Nasdaq >3% are precisely the macro headwind for unprofitable, long-duration names like QS. A stabilizing rate path plus policy support for domestic battery supply chains would be the key sentiment tailwind.
QuantumScape is a well-funded but still pre-revenue technology option: $835m net cash buys roughly two years to prove QSE-5, and the Honda R&D agreement meaningfully strengthens the licensing narrative, but zero sales, ~$100m quarterly burn, insider selling into strength, and an 18.7%-short, hold-to-sell Street leave the risk-reward balanced at $6.79. With the stock in a downtrend deep in its 52-week range and only ~5% to consensus, there is no urgency to own it here. Rate it HOLD, target $7.00 — accumulate only on a retest of the $5.90 floor or on hard commercial validation, and trim into narrative-driven spikes toward the 50-day.
Data source: Yahoo Finance / yfinance · fetched 7/8/2026, 7:19:27 AM